Skandinaviska Enskilda Banken AB publ trimmed its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 30.8% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 142,400 shares of the company’s stock after selling 63,400 shares during the period. Skandinaviska Enskilda Banken AB publ owned about 0.26% of Nu Skin Enterprises worth $11,737,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the business. Bbva Compass Bancshares Inc. grew its position in Nu Skin Enterprises by 12.8% in the 2nd quarter. Bbva Compass Bancshares Inc. now owns 6,301 shares of the company’s stock worth $493,000 after purchasing an additional 716 shares in the last quarter. Securian Asset Management Inc boosted its stake in Nu Skin Enterprises by 12.1% in the second quarter. Securian Asset Management Inc now owns 6,835 shares of the company’s stock valued at $534,000 after acquiring an additional 740 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in Nu Skin Enterprises by 21.3% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 4,255 shares of the company’s stock valued at $351,000 after acquiring an additional 746 shares during the last quarter. New York State Teachers Retirement System boosted its stake in Nu Skin Enterprises by 4.2% in the second quarter. New York State Teachers Retirement System now owns 20,000 shares of the company’s stock valued at $1,564,000 after acquiring an additional 800 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd boosted its stake in Nu Skin Enterprises by 162.9% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock valued at $106,000 after acquiring an additional 800 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have weighed in on NUS shares. DA Davidson started coverage on shares of Nu Skin Enterprises in a research note on Tuesday, October 9th. They issued a “buy” rating and a $92.00 target price on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $98.00 target price on shares of Nu Skin Enterprises in a research note on Tuesday, September 4th. Zacks Investment Research cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 8th. Citigroup set a $88.00 target price on shares of Nu Skin Enterprises and gave the company a “buy” rating in a research note on Thursday. Finally, Stifel Nicolaus upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their target price for the company from $57.00 to $70.00 in a research note on Thursday, August 2nd. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. Nu Skin Enterprises presently has a consensus rating of “Buy” and a consensus target price of $86.29.
NUS opened at $65.02 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.19 and a current ratio of 1.82. The stock has a market capitalization of $4.05 billion, a price-to-earnings ratio of 20.13, a P/E/G ratio of 1.78 and a beta of 1.04. Nu Skin Enterprises, Inc. has a twelve month low of $60.60 and a twelve month high of $88.68.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 7th. The company reported $0.94 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.96 by ($0.02). The company had revenue of $675.31 million during the quarter, compared to analysts’ expectations of $664.99 million. Nu Skin Enterprises had a net margin of 5.93% and a return on equity of 28.06%. The firm’s revenue was up 19.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.76 earnings per share. As a group, research analysts anticipate that Nu Skin Enterprises, Inc. will post 3.52 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Investors of record on Friday, November 30th will be paid a dividend of $0.365 per share. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend is Thursday, November 29th. Nu Skin Enterprises’s payout ratio is currently 45.20%.
In related news, General Counsel D Matthew Dorny sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $82.18, for a total transaction of $205,450.00. Following the sale, the general counsel now directly owns 33,871 shares in the company, valued at approximately $2,783,518.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 5.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/11/10/nu-skin-enterprises-inc-nus-holdings-cut-by-skandinaviska-enskilda-banken-ab-publ.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Article: Should You Consider an Index Fund?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.